PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

FDA’s Gottlieb Hits Innovators, Insurers for Blocking Biosimilar Uptake

Risk Sharing, Italian Style

Setting the Standard: William Soliman, ACMA

Advertisement
Top Story
Full Disclosure Demanded for Pharma Industry
The public and policymakers seek more transparency in pricing and product development, writes Jill Wechsler
/Read more/
Advertisement
Regulatory Information Management Best Practices
Read this Executive Summary to learn how to reduce regulatory complexity, ensure data quality and improve the user experience while ensuring compliance.
Download Now
Outcomes-Based Healthcare
The Quest to Measure Up
Outcomes-based contracting could be a potential game-changer, but several complex challenges remain in the bid to make this model a mainstay. Michelle Maskaly reports
/Read more/
Advertisement
HCP Multichannel Marketing – What Does Great Look Like?
Live Webcast: Wednesday, April 11 at 1pm EDT
Register now
Calendar
/ March 19–22: DCAT Week ’18 /
New York, NY
/ March 25–28: 14th Annual Pharma Forum /
Philadelphia, PA
/ March 28–29: Expanded Access Programs /
Washington, DC
/ April 10–12: LogiPharma 2018 /
Montreux, Switzerland
/ April 11–12: 8th Annual Global Transparency Reporting Congress /
London, UK
/ May 10–11: Pharma Marketing Summit /
Palm Beach, FL
/ June 5–7: Pharmaceutical Compliance Congress Canada /
Toronto, Canada
/ June 13–14: Connected Devices in Life Sciences /
Boston, MA
/ June 19–20: Rare Disease Innovation Summit /
Boston, MA
/ October 15–17: 28th Annual Sharing Conference: Compliance /
National Harbor, MD
Translational Science
BMS and Biomarker Research
Saurabh Saha, SVP and Global Head of Translational Medicine at Bristol Myers-Squibb, shares his perspectives on the current biomarker landscape, the role of translational medicine, and how BMS is working to advance biomarker research across their R&D portfolio
/Read more/
Advertisement
CRO Consolidation: A Sinister Threat or Windfall for Pharma?
Live Webcast: Tuesday, March 27 at 1:00pm EDT
Register now
China
Four Key Areas Shaping the Chinese Pharmaceutical Industry
Jin Zhang outlines four key areas that impacted Chinese pharma in 2017 and looks at how their effects will shape the industry in the years ahead
/Read more/
Audio
The Pharm Exec Podcast:
Episode 3
In this episode of Pharm Exec’s new podcast series, the editors talk to Devyn Smith, Sigilon Therapeutics’ chief strategy officer, about pharma’s reputation in the US and Europe
/Click here to listen/
Advertisement
Using Artificial Intelligence to Drive Innovation in the Life Sciences
Thursday, March 22 at 1:00pm EDT
Register now
Industry update
//Astellas (Northbrook, IL) announced three senior-level changes in its global Legal and Human Resources organizations. // Roderick (Rod) Christmon was promoted to executive director, Medical & Development, leading the Human Resources team for the global function. // Effective April 1, Matt Silversten is promoted to vice president, Legal Head of Litigation and Investigations, overseeing global legal support. // Brian Taylor is also promoted to vice president, Legal Head of Business Development/Alliance Management. // Oxford BioTherapeutics Oxford, UK, and San Jose, CA) announced the appointment of Abderrahim (Rahim) Fandi, M.D. PhD to the newly created position of Chief Medical Officer. //
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com